drugset / Trial / NCT01502813

Citicoline, Creatine, and Omega-3 Effects in Middle Age Women

NCT01502813

Completed 40 enrolled Deborah Yurgelun-Todd
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the functional effects of a citicoline, creatine, and omega-3 fatty acids combination when administered for a duration of four weeks (28 days) to non-psychiatric adult female participants.

Timeline

Start
2012-02-01
Primary completion
2018-10-30
Completion
2019-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Citicoline Other / unclassified 500 mg
Subject Creatine Other / unclassified 5 g
Subject Omega-3 fatty acids Unknown 2 g

Indications

No indication recorded.